Press Releases
Quantum X Labs Files U.S. Patent Application for High Precision Quantum Atomic Clock for Potential Use in the Aerospace & Defense Industries
Tel Aviv, Israel, May 04, 2026 (GLOBE NEWSWIRE) -- Quantum X Labs Inc. (Nasdaq: QXL) (“QXL” or the “Company”), an advanced technologies company (formerly known as Viewbix Inc. (Nasdaq: VBIX)), announced today the filing of a U.S. patent application covering a novel compact atomic clock. By interrogating rubidium atoms with correlated optical fields the system suppresses existing atom clocks...
SOL Strategies Announces Definitive Agreement to Acquire Houdini Swap, Expanding Privacy Focus and Acquiring Diversified Revenue Streams
Adding fifth revenue stream, cross-chain distribution across over 100 blockchain networks and a profitable business Toronto, Ontario--(Newsfile Corp. - May 4, 2026) - SOL Strategies Inc. (CSE: HODL) (NASDAQ: STKE) ("SOL Strategies" or the "Company"), one of the first publicly traded companies dedicated to growing and building the Solana Economy, today announced it has entered into a definitive agreement to acquire HoudiniSwap LLC ("Houdini"), a non-custodial, privacy-focused cross-chain swap aggregator, for USD $18 million, payable in cash and shares of the Company (the "Acquisition"). Houdini, which generated approximately USD $13mm in revenue in 2025 with over half of trailing 12-month volume touching the Solana blockchain, is a digital asset infrastructure business that helps users access competitive swap routes across centralized exchanges, decentralized exchanges, and blockchain bridges without taking custody of funds...
Gyre Therapeutics Completes Acquisition of Cullgen to Create U.S.- and China-based Fully Integrated Biopharmaceutical Company
Post-closing combined company has revenue-producing commercial asset and a robust pipeline of products and product candidates to address multiple therapeutic areas with a focus on fibrosis and inflammatory diseases. China innovation engine provides cost-efficient vehicle for discovery and early-stage development of targeted protein degraders and degrader-antibody conjugates...
Worksport (NASDAQ:WKSP) Invited to Present at D. Boral 2026 Global Conference
Worksport CEO Steven Rossi will share the Company's growth story with institutional investors in New York City as Worksport continues expanding commercial execution, product availability, and investor visibility. Existing shareholders may also request meetings with Worksport management on May 6 and May 7...
Cannabix Technologies Announces Delivery of Marijuana Breath Test (MBT) to Workplace Drug and Alcohol Testing Clinic
VANCOUVER, British Columbia, May 04, 2026 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTCID: BLOZF) (Frankfurt: 8CT) (the “Company” or “Cannabix”) developer of marijuana and alcohol breath testing devices for workplace safety and law enforcement, is pleased to announce the delivery of its Marijuana Breath Test (“MBT”) products to a drug and alcohol testing clinic serving workplace clients in eastern Canada. The client provides drug testing and process services, delivering results to commercial companies, private businesses, government agencies and individual clients. The delivery was completed through an authorized reseller...
Polyrizon Announces U.S. Patent Expansion for Its Intranasal Drug Delivery Platform
Raanana, Israel, May 04, 2026 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (the “Company” or “Polyrizon”), a development-stage biotech company specializing in the development of innovative intranasal hydrogels, today announced the submission of amended claims in its U.S. patent application for its proprietary intranasal drug delivery platform...
AITX to Present at the LD Micro Invitational XVI
Showcasing AI Driven Approach to Physical Security and Expanding Market Reach Detroit, Michigan, May 04, 2026 (GLOBE NEWSWIRE) -- Artificial Intelligence Technology Solutions, Inc. (the “Company”) (OTCID:AITX), a global leader in AI-driven security and productivity solutions for enterprise clients, today announced that it will be participating in the 16th Annual LD Micro Invitational at the Luxe Sunset Boulevard Hotel in Los Angeles, May 18th and 19th, 2026. Steve Reinharz, CEO/CTO and founder of AITX is scheduled to present on Monday, May 18, 2026, at 3:00 PM PT...
KinderCare Celebrates Teachers with Child Care Tuition Support
LAKE OSWEGO, Ore.--(BUSINESS WIRE)--KinderCare Learning Companies, Inc. (NYSE: KLC) (“KinderCare”), the nation's leading provider of high-quality early childhood education and care, is celebrating Teacher Appreciation Week with a special thank you to K-12 teachers and district staff. KinderCare will offer staff and teachers at any school district that its before- and after-school brand Champions operates in with a tuition benefit of 10% off child care at any KinderCare Learning Center (KCLC). “...
NextGen Healthcare Receives Bronze Stevie® Award for “AI-Driven Success in Action” in 2026 American Business Awards®
NEW YORK--(BUSINESS WIRE)-- #NextGenHealthcare--NextGen Healthcare, a leading provider of innovative, cloud-based healthcare technology solutions, has received a Bronze Stevie Award for “AI-Driven Success in Action” in the 2026 American Business Awards, the premier U.S. business awards program. Nominated for the category of “AI in Healthcare Achievement,” NextGen Healthcare was recognized by the judging panel for “showing real improvements in provider productivity, patient access, and operational efficiency” and...
Atlas Lithium Corporation to Present at the Precious Metals & Critical Minerals Virtual Investor Conference May 5th
Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com
Pinnacle West Reports 2026 First-Quarter Financial Results
PHOENIX--(BUSINESS WIRE)--Pinnacle West reports first-quarter 2026 financial results driven by hotter-than-normal weather.
Infleqtion to Report First Quarter 2026 Financial Results on May 14, 2026
LOUISVILLE, Colo.--(BUSINESS WIRE)--Infleqtion (NYSE: INFQ) (the “Company”), a global leader in quantum computing and quantum sensing powered by neutral-atom technology, today announced that it will release its financial results for the quarter ended March 31, 2026, on Thursday, May 14, 2026, after the financial markets close. The Company will host a conference call at 4:30 PM Eastern Time the same day to discuss financial results. The call will be webcast live on the Company's Investor Relatio...
Niagen Bioscience Launches Niagen Plus Telehealth Platform, Unveiling At-Home Injection Kit Offering
LOS ANGELES--(BUSINESS WIRE)---- $NAGE #AtHomeInjection--Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announced the launch of its clinician-directed telehealth platform under Niagen™ Plus, enabling eligible patients in the U.S. to access prescription-only, pharmaceutical-grade Niagen (patented nicotinamide riboside chloride, NRCl) from home with the first-of-its-kind Niagen At-Home Injection Kit. The launch m...
Dot Ai to Host First Quarter 2026 Earnings Call on May 11 at 4:30 p.m. Eastern Time
LAS VEGAS, NV / ACCESS Newswire / May 4, 2026 / Dot Ai (Nasdaq:DAIC) ("Dot Ai" or the "Company"), an IoT and AI-based SaaS company redefining asset intelligence for industrial technology, will release financial results for the first quarter ended March 31, 2026 after market close on May 11, 2026. Management will host an investor conference call at 4:30 p.m...
Kopin Corporation to Host First Quarter 2026 Earnings Call on Tuesday, May 12, 2026 at 8:30 AM Eastern Time
WESTBOROUGH, Mass.--(BUSINESS WIRE)--Kopin Corporation (Nasdaq: KOPN) (“Kopin” or the “Company”), a leading provider of application-specific optical systems and high-performance microdisplays for defense, training, enterprise, industrial, consumer and medical products, today announced it will release select unaudited financial results for the first quarter ended March 28, 2026 before market open on Tuesday, May 12, 2026. Management will host an investor conference call at 8:30 AM Eastern time o...
Fortress Biotech to Participate in the H.C. Wainwright 2nd Annual Royalty Company Virtual Conference
MIAMI, May 04, 2026 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on acquiring and advancing assets to enhance long-term value for shareholders through product revenue, equity holdings and dividend and royalty income, today announced that Lindsay A. Rosenwald, M.D., Chairman, President and Chief Executive Officer, will participate in a fireside chat at the H.C. Wainwright 2nd Annual Royalty Company Virtual Conference, taking place on Wednesday, May 6, 2026. The fireside chat is scheduled to begin at 12:30pm ET...
NeoVolta Announces Timing of Third Quarter Fiscal 2026 Earnings Release and Conference Call
SAN DIEGO, May 04, 2026 (GLOBE NEWSWIRE) -- NeoVolta Inc. (NASDAQ: NEOV) ("NeoVolta" or the "Company"), a U.S.-based energy technology company delivering scalable energy storage solutions, today announced that it will release its third quarter fiscal 2026 results after market close on Thursday, May 14, 2026...
Stoneridge, Inc. to Broadcast its First Quarter 2026 Conference Call on the Web
NOVI, Mich., May 4, 2026 /PRNewswire/ -- Stoneridge, Inc. (NYSE: SRI) will webcast its first quarter 2026 earnings conference call live on Thursday, May 7, 2026, at 9:00 a.m.
Barfresh to Present at the LD Micro Invitational XVI
LOS ANGELES, May 04, 2026 (GLOBE NEWSWIRE) -- Barfresh Food Group, Inc. (the “Company” or “Barfresh”) (Nasdaq: BRFH), a provider of frozen, ready-to-blend and ready-to-drink beverages, today announced that Riccardo Delle Coste, the Company's Chief Executive Officer, and Lisa Roger, the Company's Chief Financial Officer, will present at the LD Micro Invitational XVI, being held May 17-19, 2026 in Los Angeles, CA. Barfresh's presentation is scheduled to begin at 1:00 PM Pacific Time (4:00 PM Eastern Time) on Tuesday, May 19th...
Caris Life Sciences Receives MolDX Approval for Caris ChromoSeq, Advancing Access to Comprehensive Genomic Profiling for Myeloid Malignancies
IRVING, Texas, May 4, 2026 /PRNewswire/ -- Caris Life Sciences (NASDAQ: CAI), a leading, patient‑centric, next‑generation AI TechBio company and precision medicine pioneer, today announced that Caris ChromoSeq™ has received MolDX approval, a key milestone supporting broader clinical access to Caris' comprehensive whole genome tumor profiling assay for myeloid malignancies. The Molecular Diagnostic Services (MolDX) program, administered by Palmetto GBA on behalf of the Centers for Medicare & Medicaid Services (CMS), evaluates molecular diagnostic tests to determine whether they demonstrate clinical validity and utility to support coverage and reimbursement decisions...
Following Keynote Recognition, NVIDIA Showcases Eco Wave Power's Vision for AI-Driven Wave Energy Technology
Short film published across NVIDIA's global social media platforms highlights Eco Wave Power's approach to combining artificial intelligence and wave energy MIAMI, Fla., May 4, 2026 /PRNewswire/ -- Eco Wave Power Global AB (NASDAQ: WAVE), a leading onshore wave energy technology company, today announced that NVIDIA has featured the Company in a short film published across its global social media platforms, highlighting Eco Wave Power's vision of leveraging artificial intelligence to optimize wave energy generation...
Axe Compute Inc. (NASDAQ: AGPU) CEO Chris Miglino to Appear on Schwab Network May 4 and Cheddar May 6
PITTSBURGH, May 04, 2026 (GLOBE NEWSWIRE) -- Axe Compute Inc. (NASDAQ: AGPU), a neocloud AI infrastructure platform delivering dedicated enterprise GPU compute capacity at global scale, today announced that Chief Executive Officer Christopher Miglino will appear in two national broadcast interviews this week. The appearances follow the Company's April 22, 2026 announcement of a $260 million, three-year enterprise contract for a 2,304-GPU NVIDIA B300 deployment, representing the largest enterprise engagement in Axe Compute's history...
Alico to Present at the LD Micro Invitational XVI
FORT MYERS, Fla., May 04, 2026 (GLOBE NEWSWIRE) -- Alico, Inc. (“Alico” or the “Company”) (Nasdaq: ALCO) today announced that John Kiernan, the Company's President and Chief Executive Officer, will present and host one-on-one meetings with investors at the LD Micro Invitational XVI Conference, taking place on May 17-19, 2026 in Los Angeles, CA...
GlobalFoundries accelerates adoption of co-packaged optics for advanced AI data centers with SCALE optical module solution
MALTA, N.Y., May 04, 2026 (GLOBE NEWSWIRE) -- GlobalFoundries (Nasdaq: GFS) (GF) today announced the introduction of its SCALE™ optical module solution for co-packaged optics (CPO).
NewGen Provides Update on Fiscal Year 2025 Results and Strategic Progress
NewGen records strong balance sheet with total assets of US$32.7 million Net profit attributable to shareholders of the Company of US$9.9 million BANGKOK, May 04, 2026 (GLOBE NEWSWIRE) -- NewGenIVF Group (NASDAQ: NIVF) (“NewGen” or the “Company”), a technology-driven, diversified growth company, today outlined several highlights of its fiscal year 2025 results and the steady progress of its continued strategic transformation. More information on NewGen's results can be found in the Company's annual report on Form 20-F for the fiscal year ended December 31, 2025, (the “2025 Annual Report”) which was filed with the U.S. Securities and Exchange Commission (the “SEC”) in April 2026...
Liquidia Corporation to Report First Quarter 2026 Financial Results on May 11, 2026
MORRISVILLE, N.C., May 04, 2026 (GLOBE NEWSWIRE) -- Liquidia Corporation (Nasdaq: LQDA), a biopharmaceutical company driven by science and compassion to revolutionize care for patients with challenging respiratory and vascular diseases, announced today that it will report its first quarter 2026 financial results on Monday, May 11, 2026...
Abeona Therapeutics® Announces Date of First Quarter Financial Results
CLEVELAND, May 04, 2026 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced it will host a conference call on Wednesday, May 13, 2026 at 8:30 a.m. ET to discuss its financial results for the first quarter of 2026 and corporate progress.
DeFi Development Corp. Launches $200 Million At-The-Market Facility (ATM) to Buy More SOL
BOCA RATON, FL, May 04, 2026 (GLOBE NEWSWIRE) -- DeFi Development Corp. (Nasdaq: DFDV) (the “Company”), the first US public company with a treasury strategy built to accumulate and compound Solana (“SOL”), today announced a $200 million at-the-market equity program. Proceeds will be deployed into SOL, working capital, and strategic initiatives...
Sculptor Real Estate and Trinity Investments Acquire JW Marriott Marco Island Beach Resort from MassMutual
MIAMI--(BUSINESS WIRE)--A joint venture between Sculptor Real Estate Income Strategy—Sculptor Real Estate's core plus strategy focused on differentiated, stabilized, income-producing real estate—and Trinity Investments (“Trinity”), a global hospitality-focused investment firm, announced today the acquisition of the JW Marriott Marco Island Beach Resort (the “Property”), a luxury beachfront resort located on Florida's Gulf Coast, from MassMutual, a leading mutual life insurance company. Situated...
Gloo Completes Acquisition of EnterpriseMarketdesk (EMD) Bringing AI-enabled Workday Services and Expertise to the Gloo Platform
BOULDER, Colo.--(BUSINESS WIRE)--Gloo (Nasdaq: GLOO), a leading technology platform serving the faith and flourishing ecosystem, today announced it has completed the acquisition of EnterpriseMarketdesk (EMD), an established Workday Services Partner providing consulting, implementation, and support services to nonprofit and mid-market organizations. The transaction, which was announced on April 14, brings a comprehensive suite of AI-enabled Workday services and expertise onto the Gloo platform...
The LUNA Brand Debuts New "Easy to Love" Campaign Starring Jessica Alba as Brand Fan Turned Ambassador
New era for the deliciously good snacking brand is marked by first campaign and bar innovation in years EAST HANOVER, N.J., May 4, 2026 /PRNewswire/ -- LUNA Bar, the gluten-free snack bar brand dedicated to helping consumers elevate the moment, today launched its new "Easy to Love" creative campaign, starring longtime brand fan Jessica Alba as its inaugural ambassador...
Epique Realty Selects RESAAS for Luxury Referral Platform
VANCOUVER, BC, May 4, 2026 /PRNewswire/ - RESAAS Services Inc. ("RESAAS" or "the Company") (TSXV: RSS) (OTCQB: RSASF), a leading provider of technology solutions for the real estate industry, is pleased to announce that Epique Realty has selected RESAAS to power its international referral network for its luxury division, Epique Estates. Founded as a next-generation, agent-focused brokerage, Epique Realty has rapidly expanded across North America, building a network of thousands of agents supported by proprietary technology, AI-driven tools, and a comprehensive suite of benefits...
Alnylam to Present New Analyses at Heart Failure 2026 Underscoring Consistent Clinical Profile of Vutrisiran in ATTR-CM
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced it will present new data analyses for vutrisiran in patients with the cardiomyopathy of wild-type or hereditary transthyretin-mediated amyloidosis (ATTR-CM) at Heart Failure 2026, a scientific congress of the European Society of Cardiology, taking place May 9-12, 2026, in Barcelona, Spain. ATTR-CM is a heterogeneous and rapidly progressive disease, and patients...
Thermo Fisher Scientific Unveils an Integrated Platform to Advance Scalable Cell Therapy Manufacturing
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, today introduced the Gibco™ CTS™ DynaXS™ Single Use Bioreactor, a purpose-built expansion platform designed to help cell therapy developers scale manufacturing with precise control, flexibility, and regulatory readiness. As cell therapies move from early research into clinical development and commercialization, manufacturers face increasing pressure to transition from static culture systems to s...
NerdWallet Announces Winners of Its 2026 Best-Of Awards for Mortgage Lenders
SAN FRANCISCO--(BUSINESS WIRE)--NerdWallet, Inc. (Nasdaq: NRDS), which provides trustworthy financial guidance to consumers and small and mid-sized businesses (SMBs), today announced the winners of its 2026 Best-Of Awards for Mortgage Lenders. This award recognizes the top mortgage lenders meeting the needs of home buyers and homeowners. To determine this year's winners, seven NerdWallet mortgage experts with more than 30 years of combined experience evaluated 48 lenders across 12 categories. T...
Bicara Therapeutics to Report First Quarter 2026 Financial Results and Business Updates on May 11, 2026, at 8:30 AM ET
BOSTON, May 04, 2026 (GLOBE NEWSWIRE) -- Bicara Therapeutics Inc. (Nasdaq: BCAX), a clinical-stage biopharmaceutical company committed to bringing transformative bifunctional therapies to patients with solid tumors, today announced that it will report first quarter 2026 financial results and business updates before the market opens on Monday, May 11, 2026. Bicara will host a conference call to discuss the financial results and business updates at 8:30 a.m. ET the same day. Individuals may register for the conference call by clicking the link here. Once registered, participants will receive dial-in details and a unique PIN that will allow them to access the call. To access the live webcast, please visit the “Events & Presentations” section within the Investors page on the Bicara website. A replay of the webcast will be available for 30 days following the event...
Higher Prices Sustained Small Business Sales Growth in April, Fiserv Data Shows
Fiserv releases April 2026 Fiserv Small Business Index, indicating sales growth in the month was driven by higher prices consumers are paying at checkout.
NV-387 for The Treatment of Measles is Granted Orphan Drug Designation by The US FDA
SHELTON, CT / ACCESS Newswire / May 4, 2026 / NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) (the "Company"), and a clinical stage, leading global pioneer in the development of broad-spectrum antivirals based on host-mimetic nanomedicine technology that viruses cannot escape, announced today that its clinical stage, broad-spectrum, antiviral drug NV-387 has been granted an "Orphan Drug Designation" (ODD) by the US FDA Office of Orphan Products Development (OOPD). The orphan drug designation will qualify NanoViricides for incentives including: Tax credits for qualified clinical trials; Exemption from certain user fees; Potential seven years of market exclusivity after approval; according to the US FDA[1]...
Firefly Aerospace Subsidiary SciTec Receives Agreement to Advance Space Force's Space-Based Missile Defense Under Golden Dome
SciTec selected to support $3.2 billion Space-Based Interceptor program for Golden Dome SciTec selected to support $3.2 billion Space-Based Interceptor program for Golden Dome
Newtek Bank, N.A. Customers Now Have the Ability to Receive Instant Payments Through the FedNow® Service and RTP® Network 24/7/365
BOCA RATON, Fla., May 04, 2026 (GLOBE NEWSWIRE) -- NewtekOne, Inc. (NASDAQ: NEWT) (“NewtekOne”) announced that its bank subsidiary, Newtek Bank, N.A. (“Newtek Bank”), now offers its commercial banking customers the capability to receive instant payments through the Federal Reserve's FedNow Service and The Clearing House's RTP network twenty-four hours a day, seven days a week, 365 days per year...
Gladstone Commercial Corporation Earnings Call and Webcast Information
MCLEAN, VA / ACCESS Newswire / May 4, 2026 / Gladstone Commercial Corporation (Nasdaq:GOOD) announces the following event: What: Gladstone Commercial Corporation's First Quarter Ended March 31, 2026 Earnings Call & Webcast When: Wednesday, May 6, 2026 @ 8:30 a.m. ET Website: https://event.choruscall.com/mediaframe/webcast.html?webcastid=HNYZFOLf How: By webcast -- Log on to the web at the address above By phone -- Please call (877) 407-9045 Contact: Gladstone Commercial Corporation, (703) 287-5893 A conference call replay will be available after the call and will be accessible through May 13, 2026...
C2 Blockchain Advances Toward 1 Billion DOG (Bitcoin) Treasury as Accumulation Continues
Treasury Increased by Approximately 41.2 Million DOG Since Prior Disclosure MIAMI BEACH, FL / ACCESS Newswire / May 4, 2026 / C2 Blockchain Inc. (OTCID:CBLO), a blockchain infrastructure and digital asset treasury company, today announced that its corporate holdings of DOG (Bitcoin) have increased to 988,703,937.0 DOG coins. The updated treasury balance reflects the acquisition of approximately 41,196,561 additional DOG coins since the Company's most recent disclosure of 947,507,376 DOG coins, representing continued implementation of the Company's digital asset treasury strategy...
Jaguar Health Expands Neonorm Franchise with Introduction of Neonorm Dog for Companion Animal Gut Health
Neonorm Dog extends Jaguar's existing Neonorm product franchise beyond foals and calves to provide dog owners with access to a plant-based product designed to support normal stool formation, gut hydration, and bowel health Expansion builds on Jaguar's focus on sustainably derived, plant-based gastrointestinal products for people and animals SAN FRANCISCO, CA / ACCESS Newswire / May 4, 2026 / Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar") today announced the planned launch of Neonorm Dog, a new extension of the Company's Neonorm franchise for companion animals. Neonorm Dog is designed to provide dog owners with access to a plant-based, non-prescription product intended to support normal stool formation, gut hydration, and bowel health in dogs...
Caldwell Announces TSX Approval of Normal Course Issuer Bid
TORONTO, ON / ACCESS Newswire / May 4, 2026 / Talent acquisition firm The Caldwell Partners International Inc. ("Caldwell" or the "Company") (TSX:CWL)(OTCQX:CWLPF) announces that the Toronto Stock Exchange (the "TSX") has accepted Caldwell's notice to make a normal course issuer bid (the "2026 Bid") to purchase for cancellation up to 2,023,669 common shares in the capital of the Company ("Common Shares") in total, being 10% of the public float of 20,236,698Common Shares as at April 22, 2026, to be transacted through the facilities of the TSX or through a Canadian alternative trading system, at prevailing market prices or as otherwise permitted. The actual number of Common Shares that may be purchased pursuant to the 2026 Bid will be determined by management and the Investment Committee of the Company ("Management")...
FibroBiologics Announces Release of CYWC628 Drug Product for Phase 1/2 Diabetic Foot Ulcer Clinical Trial
HOUSTON, May 04, 2026 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the development of therapeutics and potential cures for chronic diseases using fibroblasts and fibroblast-derived materials, today announced the release of the first batch of its CYWC628 drug product to support its Phase 1/2 clinical trial in patients with diabetic foot ulcers (DFUs)...
RESEARCH FRONTIERS TO HOST FIRST QUARTER 2026 CONFERENCE CALL
WOODBURY, NY, May 04, 2026 (GLOBE NEWSWIRE) -- Research Frontiers Inc. (Nasdaq: REFR) announced today that it will release its first quarter 2026 financial results on Thursday, May 7, 2026. Research Frontiers will also host a conference call at 4:30 p.m. Eastern Time on Thursday, May 7, 2026 to discuss its first quarter 2026 financial and operating results, as well as recent developments...
AimwellBio Reports Strong Early Demand From Hospital Systems and Researchers as FHIN Founding Cohort Takes Shape
NEW YORK CITY, NY / ACCESS Newswire / May 4, 2026 / Aimwell Partners Inc. (OTCID:AIMN), parent company of AimwellBio, today announced that initial engagement with hospital systems and hospitalists has generated strong early-stage interest in the company's Federated Health Intelligence Network (FHIN) founding cohort. Following a series of meetings conducted over the past two weeks, including a session that resulted in a hospital system expressing interest in onboarding its research staff for platform evaluation, the company is accelerating its FHIN enrollment timeline and pursuing memberships in multiple scientific and medical associations to broaden network credibility and contributor access...
Satellogic Expands Global Sales Force with Senior Defense and Intelligence Industry Veterans
Three Senior Hires with Deep Industry Experience Join Satellogic as Demand forPersistent, Sovereign Geospatial Intelligence Accelerates NEW YORK, May 04, 2026 (GLOBE NEWSWIRE) -- Satellogic, Inc. (NASDAQ: SATL), a vertically integrated geospatial company delivering high-resolution Earth Observation (EO) at unprecedented scale and economics, today announced the addition of three senior industry veterans to its global sales organization: Matt Clark, Brett Davis, and Jonathan Lee. The hires come as defense and intelligence customers worldwide accelerate their pursuit of persistent, sovereign monitoring capabilities...
Red Light Holland Announces Intention to Rebrand
New name and branding to be announced in the coming weeks, better aligned with the Company's scientific mandate and all business segments Name change resolution to be voted on by shareholders at the upcoming Annual General and Special Meeting ("AGSM") on May 11, 2026 Company urges all shareholders to vote IN FAVOUR of the name change resolution to support the rebranding exercise Rebranding reflects the combined focus on clinical research, GMP manufacturing, FDA-aligned drug development, and the advancement of patented botanical psychedelic drug candidates including PEX010 Toronto, Ontario--(Newsfile Corp. - May 4, 2026) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light Holland" or the "Company") today announced its intention to undertake a corporate rebranding, including a change of the Company's name, following the closing of the acquisition of Filament Health Corp. ("Filament") (the "Transaction"). The proposed rebranding remains subject to shareholder approval of a name change resolution at the Company's upcoming Annual General and Special Meeting ("AGSM") scheduled for May 11, 2026...
Sitka Reports 94.3% Gold Recovery and 84.7% Tungsten Recovery from Metallurgical Testing at the Rhosgobel Deposit at Its Rc Gold Project, Yukon
Gold recovery averaging 94.3% from Rhosgobel deposit utilizing conventional whole ore cyanidation leaching at a grind size of 75 microns; Results from initial metallurgical testing returned a tungsten recovery of 84.7% in rougher concentrate using conventional flotation with a very low mass pull of less than 1%; Initial metallurgy confirms high recoveries for both tungsten and gold and demonstrates that tungsten could be a valuable by-product of potential future production at Rhosgobel Multiple occurrences of visible gold and tungsten mineralization have been observed in the initial 2026 drill core at Rhosgobel 60,000 m diamond drill program underway; 30,000 m of drilling planned at Rhosgobel in 2026 Four diamond drill rigs are currently active on the property; two additional rigs anticipated to mobilize in the coming weeks Vancouver, British Columbia--(Newsfile Corp. - May 4, 2026) - Sitka Gold Corp. (TSXV: SIG) (FSE: 1RF) (OTCQX: SITKF) ("Sitka" or "Sitka Gold" or the "Company") is pleased to announce positive results from initial metallurgical testwork completed for gold and tungsten recoveries at the newly discovered Rhosgobel Gold Deposit (inferred mineral resource estimate of 2.25 million ounces of gold with 100.68 Mt @ 0.70 g/t Au; see news release dated February 25, 2026) at its flagship RC Gold Project in Yukon. The results of the initial testwork demonstrate robust gold recoveries ranging from 91.8% - 97.3% with an overall average of 94.3% (see Table 3) at Rhosgobel utilizing whole ore bottle roll testing which represents Carbon in Leach ("CIL")/Carbon in Pulp ("CIP") processes, the most commonly used milling gold recovery method...
Neurocrine Biosciences Announces New Survey Results Showing Significant Burden of Tardive Dyskinesia on Employment
Approximately 1 in 5 surveyed working adults with tardive dyskinesia reported quitting their job due to untreated involuntary movements1 Respondents also reported missing an average of 8 hours of work or school per week due to tardive dyskinesia prior to treatment1 Findings released during Tardive Dyskinesia Awareness Week SAN DIEGO, May 4, 2026 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced the release of findings from a new survey revealing the significant impact of tardive dyskinesia (TD) on people's ability to work, go to school, volunteer or actively look for employment. About one in five surveyed working adults with TD reported quitting their job due to TD symptoms prior to treatment.1 Findings are released in recognition of Tardive Dyskinesia Awareness Week (May 3-9) to underscore the importance of increased awareness, early recognition and appropriate management of TD...
Atossa Therapeutics Receives FDA Rare Pediatric Disease Designation for (Z)-Endoxifen for McCune-Albright Syndrome
Designation expands (Z)-endoxifen program into rare pediatric endocrine disorder and qualifies Atossa for a Priority Review Voucher award upon approval SEATTLE, May 4, 2026 /PRNewswire/ -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) ("Atossa" or the "Company"), a clinical-stage biopharmaceutical company developing novel therapies in oncology and other areas of high unmet clinical need, today announced that the U.S. Food and Drug Administration ("FDA") has granted Rare Pediatric Disease ("RPD") designation to (Z)-endoxifen for the treatment of McCune-Albright Syndrome ("MAS") in females. RPD designation is granted to drug candidates intended to treat serious or life-threatening diseases that primarily affect individuals from birth to 18 years of age...
AGNICO EAGLE ANNOUNCES RENEWAL OF NORMAL COURSE ISSUER BID
(All amounts expressed in U.S. dollars unless otherwise noted) TORONTO, May 4, 2026 /PRNewswire/ - Agnico Eagle Mines Limited (NYSE: AEM) (TSX: AEM) ("Agnico Eagle") announced today that further to its news release dated April 30, 2026, it has received approval from the Toronto Stock Exchange (the "TSX") of Agnico Eagle's notice of intention to renew its normal course issuer bid (the "NCIB"). Under the NCIB, Agnico Eagle may purchase for cancellation, on the open market at its discretion, during the period commencing on May 6, 2026 and ending on the earlier of May 5, 2027 and the completion of purchases under the NCIB, up to the lesser of: (i) 25,024,469 common shares of Agnico Eagle ("Common Shares"), which is 5% of the issued and outstanding Common Shares; and (ii) that number of Common Shares that can be purchased by Agnico Eagle under the NCIB for an aggregate purchase price, excluding commissions, of not more than $2,000,000,000, subject to the normal terms and limitations of such bids...
CENTURY LITHIUM ANNOUNCES MANAGEMENT APPOINTMENTS TO ADVANCE ANGEL ISLAND LITHIUM PROJECT, NEVADA
VANCOUVER, BC, May 4, 2026 /PRNewswire/ - Century Lithium Corp. (TSXV: LCE) (OTCQX: CYDVF) (Frankfurt: C1Z) ("Century Lithium" or the "Company") is pleased to announce the following management appointments. These individuals will reinforce the Company's technical, environmental, and operational capabilities as it advances its 100%-owned Angel Island Lithium Project ("Angel Island") in Esmeralda County, Nevada, USA through permitting and pre-construction development programs...
MSA Safety Announces 56 Consecutive Years of Annual Dividend Increases
PITTSBURGH, May 4, 2026 /PRNewswire/ -- The Board of Directors of MSA Safety Incorporated (NYSE: MSA) today approved the company's 56th consecutive annual dividend increase, raising the quarterly dividend from $0.53 per common share to $0.54 per common share. The change reflects a 2% increase in the quarterly dividend and a 2% increase in 2026 dividends per common share compared to 2025...
Kadestone Capital Corp. Reports Q4 and Full Year 2025 Financial Results
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES Vancouver, British Columbia--(Newsfile Corp. - May 4, 2026) - Kadestone Capital Corp. (TSXV: KDSX) ("Kadestone" or the "Company"), a vertically integrated property company today announced its financial results for the year ended December 31, 2025. Financial Results For the year ended December 31, 2025, the Company reported a net loss of $6,186,532, or $0.13 per share, compared to a net loss of $5,356,082(1), or $0.11(1) per share, for the same period in the prior year...
DarioHealth to Report First Quarter 2026 Results on Wednesday, May 13, 2026
Company to host conference call and webcast at 8:30 a.m. Eastern Time NEW YORK, May 4, 2026 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, announced today that it will release its financial results for the 1st quarter ended March 31st, 2026 and will host a conference call and webcast at 8:30 a.m...
Quantum Computing Inc. to Host First Quarter 2026 Shareholder Call on Monday, May 11, 2026
HOBOKEN, N.J., May 4, 2026 /PRNewswire/ -- Quantum Computing Inc. ("QCi" or the "Company") (Nasdaq: QUBT), a quantum optics and integrated photonics company, today announced that the Company will host a conference call and webcast on Monday, May 11, 2026 at 4:30 p.m.
Schrödinger to Participate in Upcoming Investor Conferences
NEW YORK--(BUSINESS WIRE)--Schrödinger, Inc. (Nasdaq: SDGR) today announced that management will participate in the following conferences in May: BofA Securities 2026 Healthcare Conference: Fireside chat on Wednesday, May 13, 2026, at 5:20 p.m. E.T. RBC 2026 Global Healthcare Conference: Fireside chat on Tuesday, May 19, 2026 at 2:05 p.m. E.T. The live discussions can be accessed in the “Investors” section of Schrödinger's website and will be archived for approximately 90 days following the eve...
Quantum eMotion Announces Launch and Availability of eShield-Q, a Runtime Cryptographic Protection Platform for the AI and Quantum Era
New platform designed to protect cryptographic operations during execution, combining quantum entropy, memory-secure cryptography, and hardened runtime protection Montreal, Quebec--(Newsfile Corp. - May 4, 2026) - Quantum eMotion Corp. (NYSE American: QNC) (TSXV: QNC) (FSE: 34Q0) ("QeM" or the "Company"), a leader in quantum-secure cybersecurity solutions, is pleased to announce the launch and availability of eShield-Q, a new cybersecurity platform designed to address one of the fastest-growing risks in the digital economy: the exposure of cryptographic operations during application runtime. As organizations scale AI infrastructure, cloud platforms, identity systems, digital services, and secure communications, the attack surface continues to expand...
Academy Sports + Outdoors Announces Offering of Senior Secured Notes
KATY, Texas, May 4, 2026 /PRNewswire/ -- Academy Sports and Outdoors, Inc. ("Academy") (Nasdaq: ASO) today announced that its wholly-owned subsidiary, Academy, Ltd. (the "Issuer"), intends to offer $500 million aggregate principal amount of senior secured notes due 2031 (the "Notes") in a private offering that is exempt from the registration requirements of the Securities Act of 1933, as amended (the "Securities Act"), subject to market and other conditions...
Reliance Global Group Completes Transformative Investment in Late-Stage Radiopharmaceutical Innovator Innervate Through EZRA's Biotech Division
Transaction Expands EZRA International Group's Biotech Division, LifeSci Global, Into Late-Stage Radiopharmaceutical Imaging
Lexitas CEO Nishat Mehta to Speak on AI in Litigation Support at 2026 ONE Houlihan Lokey Global Conference
Lexitas CEO to join industry leaders for panel discussion on the impact of AI across litigation support services Lexitas CEO to join industry leaders for panel discussion on the impact of AI across litigation support services
Bombardier Announces Launch of US$500,000,000 New Issuance of Senior Notes due 2035 to retire Senior Notes due 2029
MONTREAL, May 04, 2026 (GLOBE NEWSWIRE) -- Bombardier Inc. (“Bombardier”) today announced that it has launched an offering of US$500,000,000 aggregate principal amount of new Senior Notes due 2035 (the “New Notes”).
Bombardier Announces Conditional Notice of Redemption for All Outstanding 7.50% Senior Notes due 2029
MONTREAL, May 04, 2026 (GLOBE NEWSWIRE) -- Bombardier Inc. (“Bombardier”) today announced that it has issued a conditional notice of redemption (the “Notice of Redemption”) for all of its outstanding 7.50% Senior Notes due 2029, in an aggregate principal amount of US$750,000,000 (the “2029 Notes”). As set forth in the Notice of Redemption, the redemption date is May 19, 2026, and the redemption price for the 2029 Notes is 103.750% of the principal amount redeemed, plus accrued and unpaid interest. The redemption of the 2029 Notes is subject to and conditioned upon Bombardier completing a new offering of debt securities in the aggregate principal amount of not less than US$500,000,000 before the May 19, 2026 redemption date (the “New Notes”); however, Bombardier may delay or waive this condition in its sole and absolute discretion. This debt redemption will be paid using proceeds from a New Notes offering and cash from Bombardier's balance sheet...
Greenheart Gold Announces New Director Appointment
Longueuil, Québec--(Newsfile Corp. - May 4, 2026) - Greenheart Gold Inc. (TSXV: GHRT) (OTCQX: GHRTF) (the "Company" or "Greenheart Gold") is pleased to announce the appointment of Joseph Brady, Investment Manager at La Mancha Resource Capital LLP, to the Company's board of directors (the "Board"). Mr. Brady was nominated by La Mancha Investments S...
CACI Appoints Christopher Monoski as Executive Vice President, Manufacturing
RESTON, Va.--(BUSINESS WIRE)-- #LimitlessPotential--CACI International Inc (NYSE: CACI) announced today the appointment of Christopher Monoski as its new Executive Vice President, Manufacturing, further strengthening the company's ability to deliver secure, mission-critical technologies across defense, intelligence, and national security programs. Monoski will report directly to President and Chief Executive Officer John Mengucci and will serve as a key member of CACI's leadership team, responsible for building and...
EVERYWHERE Communications Partners with Parsons to Enable Resilient, Beyond-Line-of-Sight Autonomous Drone Operations Under SBIR Initiative
ANNAPOLIS, Md., May 4, 2026 /PRNewswire/ -- EVERYWHERE Communications today announced a strategic partnership with Parsons Corporation (NYSE: PSN) to advance next-generation autonomous drone capabilities under a Small Business Innovation Research (SBIR) initiative, focused on enabling reliable operations in disconnected and austere environments...
Critical Elements' 10,000-Metre Drill Program at Rose West Continues to Deliver Positive Results
MONTRÉAL, QUÉBEC / ACCESS Newswire / May 4, 2026 / Critical Elements Lithium Corporation (TSX-V:CRE)(OTCQX:CRECF)(FSE:F12) ("Critical Elements" or the "Corporation") is pleased to provide assay results and an update on its Phase 1 Winter 2026 drill program, at the 100% owned Rose West Discovery ("Rose West"), located in Eeyou Istchee, Québec. Highlights The Phase 1 Winter 2026 drill program continues to deliver positive results demonstrating the successful expansion of the Rose West mineralized footprint from 450 m x 370 m to 1,250 m x 800 m, thicknesses that typically range from 10 to 40 m, and excellent lateral continuity...
Guardant Health Receives FDA Approval for Guardant360® CDx as a Companion Diagnostic for Arvinas and Pfizer's VEPPANU (vepdegestrant) for Patients with ER+/HER2- Advanced Breast Cancer with ESR1 Mutations
PALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that the U.S. Food and Drug Administration (FDA) has approved the Guardant360 CDx liquid biopsy test as a companion diagnostic for VEPPANU (vepdegestrant). VEPPANU, jointly developed by Arvinas, Inc. and Pfizer Inc., is approved for the treatment of adults with estrogen receptor-positive (ER+), human epidermal growth factor receptor 2-negative (HER2-), estrogen receptor...
EQB to announce second quarter 2026 results and host earnings call
TORONTO, May 4, 2026 /PRNewswire/ - EQB Inc. (TSX: EQB) will report its second quarter fiscal 2026 financial results after market close on May 27, 2026, and will host an earnings conference call on May 28, 2026, at 10:30 a.m. ET. EQB's Chadwick Westlake, President and Chief Executive Officer, Anilisa Sainani, Chief Financial Officer, and Marlene Lenarduzzi, Chief Risk Officer, will host the listen-only conference call and webcast...
Candel Therapeutics to Host Investor Conference Call Following Presentation of Extended Data from Phase 3 Trial of Aglatimagene Besadenovec in Localized Prostate Cancer at the American Urological Association 2026 Annual Meeting
NEEDHAM, Mass., May 04, 2026 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal immunotherapies to improve outcomes for patients with cancer, today announced that Candel's management will host a webcast and conference call on Friday, May 15, 2026 at 1:00 PM ET. The call will discuss the Company's extended follow-up data from the phase 3 clinical trial of aglatimagene besadenovec (aglatimagene or CAN-2409) in patients with intermediate- to high-risk localized prostate cancer. The discussion will follow the oral plenary presentation of these data by Mark G. Garzatto, M.D., Professor of Urology at Oregon Health & Science University and the Portland VA Medical Center, at the American Urological Association (AUA) 2026 Annual Meeting...
L'Oréal and Adeia Enter Multi-Year License Agreement
SAN JOSE, Calif., May 04, 2026 (GLOBE NEWSWIRE) -- Adeia Inc. (Nasdaq: ADEA), the technology company known for developing foundational innovations that enable next-generation solutions for the semiconductor and media industries, today announced it has entered into a multi-year license agreement with L'Oréal for access to Adeia's comprehensive media intellectual property (IP) portfolio...
Orca Energy Group Provides Update to Voluntary Application for Management Cease Trade Order
TORTOLA, British Virgin Islands, May 04, 2026 (GLOBE NEWSWIRE) -- Orca Energy Group Inc. ("Orca" or the "Company") announces that its principal regulator, the Alberta Securities Commission, has granted a management cease trade order (the "MCTO"). As previously announced on April 23, 2026 (the "MCTO News Release"), the Company applied for the MCTO due to an expected delay in filing its audited consolidated annual financial statements for the year ended December 31, 2025 (the "Financial Statements"), the related management's discussion and analysis, and its Form 52-109FV1 CEO and CFO certifications of annual filings (collectively the "Required Filings")...
Safe Pro Launches New Growth Team Led by Brian Mack as Chief Growth Officer and Benjamin Chitty as VP of Government Growth
AVENTURA, Fla., May 04, 2026 (GLOBE NEWSWIRE) -- Safe Pro Group Inc. (Nasdaq: SPAI) (Safe Pro or the Company), a developer of artificial intelligence (AI)-enabled defense, security, and situational awareness solutions, today announced the launch of a new Government contract capture team led by former Anduril Senior Business Development Director and Retired U.S. Army Officer, Mr...
Alto Neuroscience Presents Phase 2a Data for ALTO-207 in Major Depressive Disorder at SOBP Annual Meeting
MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)---- $anro #cns--Alto Neuroscience, Inc. (NYSE: ANRO), a clinical-stage biopharmaceutical company focused on precision medicines for neuropsychiatric disorders, today announced the presentation of data from a randomized, single-blind, placebo-controlled Phase 2a trial of ALTO-207 (formerly CTC-501) in patients with Major Depressive Disorder (MDD). The data were presented in a poster session at the 2026 Annual Meeting of the Society of Biological Psychiatry (SOBP). ALTO-20...
Xencor to Host Webcast to Discuss XmAb942 and XmAb412 Data Presentations at DDW
PASADENA, Calif.--(BUSINESS WIRE)--Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of cancer and autoimmune diseases, today reported final results from the Phase 1 study of XmAb942, a novel, potential best-in-class, long-acting anti-TL1A antibody for the treatment of inflammatory bowel disease (IBD). The results are being presented today at Digestive Disease Week (DDW), being held in Chicago. Tomorrow, the company will a...
Sky Quarry's 180-Million-Barrel Oil Sands Asset Subject to RFP for Accelerated Commercialization
(This release supersedes the version issued on April 29, 2026, and includes additional detail on the partnership structure in response to questions received.) WOODS CROSS, UT / ACCESS Newswire / May 4, 2026 / Sky Quarry Inc. (NASDAQ:SKYQ) ("Sky Quarry" or the "Company"), an integrated energy and environmental remediation company, announced today that it is issuing a Request for Proposals (RFP) to engage partners seeking to accelerate development and commercialization of its ~180-million-barrel¹ oil sands resource at its fully permitted PR Spring facility in Utah...
CHAR Tech Appoints Infrastructure & Capital Markets Veteran Kevin Melnyk as CFO and Reminds Shareholders of Upcoming AGM
TORONTO, ON / ACCESS Newswire / May 4, 2026 / CHAR Technologies Ltd. ("CHAR Tech" or the "Company")(TSXV:YES)(OTC:CTRNF)(FSE:68K), a leader in sustainable biomass energy solutions, is pleased to announce the appointment of Kevin Melnyk as the Company's new Chief Financial Officer (CFO), effective May 4, 2026...
1606 Corp. Signs Definitive Agreement to Acquire Sim Agro to Develop, Acquire, and Operate Data Center and Power Assets
PHOENIX, AZ / ACCESS Newswire / May 4, 2026 / 1606 Corp. (OTC:CBDW) ("1606" or the "Company") today announced it has signed a definitive agreement to acquire a majority controlling interest in Sim Agro Inc., a global power-plant operations and energy-infrastructure company. The company has been able to generate revenue from operating and consulting on power projects...
Cytta Air Launches Website Showcasing Drone, Connectivity, and U.S. Manufacturing Platform
New website highlights Cytta Air's integrated ecosystem of unmanned systems, resilient communications, proprietary antenna technologies, IGAN™ real-time collaboration platform, and advanced automated manufacturing capabilities. LAS VEGAS, NV / ACCESS Newswire / May 4, 2026 / Cytta Air today announced the launch of its new corporate website (CyttaAir.com), providing shareholders, partners, customers, and industry stakeholders with a comprehensive overview of the company's integrated technology and manufacturing platform...
Slide Insurance Expands Homeowners Coverage to California
Launches excess and surplus (E&S) lines program to address shrinking insurance market, leveraging recognized expertise as a leading coastal specialty insurer Launches excess and surplus (E&S) lines program to address shrinking insurance market, leveraging recognized expertise as a leading coastal specialty insurer
Navitas Semiconductor Appoints Davin Lee as Independent Director to its Board
Lee Brings Over 30 Years of Semiconductor and Power Management Experience as Navitas Continues its Strategic Pivot to High-Power Markets
Zoom Recognizes the Rise of AI-Powered Businesses of One with Inaugural Solopreneur 50
New recognition program and proprietary research highlight how solopreneurs are using AI to replace traditional team functions and build scalable, independent businesses New recognition program and proprietary research highlight how solopreneurs are using AI to replace traditional team functions and build scalable, independent businesses
Jerash Holdings (US), Inc. Declares Quarterly Dividend
FAIRFIELD, NJ / ACCESS Newswire / May 4, 2026 / Jerash Holdings (US), Inc. (Nasdaq:JRSH) (the "Company" or "Jerash"), which manufactures and exports custom, ready-made, sportswear and outerwear for leading global brands, announced today that its board of directors approved the payment of a regular quarterly dividend of $0.05 per share on the Company's common stock. The dividend is payable on or about May 21, 2026 to the stockholders of record as of May 14, 2026...
LOBO Claw AI Agent Completes New Round of Upgrades with DeepSeek V4 Model Integration
WUXI, China, May 04, 2026 (GLOBE NEWSWIRE) -- LOBO TECHNOLOGIES LTD. (Nasdaq: LOBO) (“LOBO” or the “Company”), an innovative electric mobility vehicles manufacturer and seller, today announced that its independently developed Claw AI Agent platform (the “Platform”) has completed a new round of upgrades and officially integrated the DeepSeek V4 large model...
Rhythm Pharmaceuticals Announces New Data Presentations in Acquired Hypothalamic Obesity at Pediatric Endocrine Society
-- Pediatric patients (n=10) with acquired hypothalamic obesity achieved sustained reductions in BMI and BMI-Z at 2.5 years of setmelanotide therapy -- -- Weight category improvements observed in pediatric patients with acquired hypothalamic obesity treated with setmelanotide -- BOSTON, May 04, 2026 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with rare neuroendocrine diseases, today announced the presentation of new data to be delivered by Rhythm and its partners at The Pediatric Endocrine Society (PES) Annual Meeting, taking place April 30-May 3, 2026, in San Francisco. “Acquired hypothalamic obesity is a complex disease that requires long-term management, particularly in pediatric patients,” said Jennifer Miller, M.D...
Senseonics Enters Into Amended Loan Agreement with Hercules to Increase Borrowing Capacity to $140 Million
GERMANTOWN, Md., May 04, 2026 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NASDAQ: SENS) a medical technology company focused on the design, development and commercialization of glucose monitoring products designed to transform lives in the global diabetes community, announced that it has entered into a Second Amendment to the Loan and Security Agreement with Hercules Capital, Inc. (NYSE: HTGC)...
Terra Innovatum Expands U.S. Presence with Pittsburgh, Pa. Headquarters and Leadership Appointments to Advance SOLO™ Licensing Readiness and FOAK Deployment
Establishes Pittsburgh headquarters to support U.S. market expansion and SOLO™ deployment Appoints experienced nuclear industry leaders, John Valentino and Michael Anness, to strengthen sales, strategy and execution Advances U.S. licensing readiness, FOAK planning, and domestic supply chain alignment PITTSBURGH, May 04, 2026 (GLOBE NEWSWIRE) -- Terra Innovatum Global N.V. (NASDAQ: NKLR) (“Terra” or the “Company”), developer of the SOLO™ Micro-Modular Reactor, today announced the establishment of Terra Innovatum Corp., its U.S. headquarters in Pittsburgh, Pa...
News Release in accordance with Canadian National Instrument 62-103
For Immediate Release News Release News Release in accordance with Canadian National Instrument 62-103 – The Early Warning System and Related Take-Over Bid and Insider Reporting Issues Rotterdam, The Netherlands, May 4, 2026 – In accordance with the requirements of Canadian National Instrument 62-103 – The Early Warning System and Related Take-Over Bid and Insider Reporting Issues, Refresco Holding B.V. ("Refresco"), a leading independent beverage solutions provider for preeminent global and local beverage brands in North America, Europe, and Australia, announces that, on May 1, 2026, it acquired, through its subsidiary 2786694 Alberta Ltd...
Evaxion to announce business update and first quarter 2026 financial results on May 7, 2026
COPENHAGEN, Denmark, May 4, 2026 - Evaxion A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company developing novel vaccines with its pioneering AI-Immunology™ platform, will provide a business update and report its first quarter 2026 financial results on Thursday May 7, 2026, before opening of the Nasdaq CM. Evaxion's Executive Management will host a conference call and webcast the same day at 14:30 CET/08:30 EST, presenting the update and results as well as taking questions...
4DMT to Participate in Upcoming Investor Conferences
EMERYVILLE, Calif., May 04, 2026 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients, today announced that management will present and participate in one-on-one meetings at upcoming investor conferences in May...
Mint Incorporation Limited Announces 1-for-10 Reverse Stock Split
Hong Kong, May 04, 2026 (GLOBE NEWSWIRE) -- Mint Incorporation Limited (“Mint” or the “Company”, NASDAQ: MIMI), a Hong Kong-based company with a new strategic focus on artificial intelligence (AI) and robotics, and an established business interior design and fit-out works provider, announces that it is implementing a reverse stock split of all of the Company's issued and unissued shares, including the Class A ordinary shares with no par value (the "Class A Ordinary Shares") and Class B ordinary shares with no par value (the “Class B Ordinary Shares,” together with the Class A Ordinary Shares, the "Ordinary Shares"), at an exchange ratio of one (1) share for ten (10) shares (the “Reverse Stock Split”). The Reverse Stock Split was approved by the Company's Board of Directors on March 31, 2026...
Kyverna Therapeutics Appoints Nadia Dac, Seasoned Commercial Leader in Neurology and Rare Disease, as Chief Commercial Officer
EMERYVILLE, Calif., May 04, 2026 (GLOBE NEWSWIRE) -- Kyverna Therapeutics, Inc. (Nasdaq: KYTX), a late-stage clinical biopharmaceutical company focused on developing cell therapies for patients with autoimmune diseases, today announced the appointment of veteran commercial leader Nadia Dac as Chief Commercial Officer, effective May 4...
ProQR Announces Annual General Meeting of Shareholders to be Held June 2, 2026
LEIDEN, Netherlands & CAMBRIDGE, Mass., May 04, 2026 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V.
Ingersoll Rand Acquires Fox s.r.l., Expanding Metering and Dosing Capabilities
DAVIDSON, N.C.--(BUSINESS WIRE)--Ingersoll Rand Inc., (NYSE: IR) a global provider of mission-critical flow creation and life science and industrial solutions, has acquired Fox s.r.l. and XF s.r.l. (“Fox”), expanding the company's metering and dosing technologies portfolio. Based in Milan, Italy, Fox manufactures hydropneumatic accumulators, pulsation dampeners, calibration pots, and instrumentation to stabilize flow and pressure in dosing systems, protecting downstream equipment and improving...
Booz Allen to Develop Prototype System for Space Force's Space-Based Interceptor Program in Support of Golden Dome
MCLEAN, Va.--(BUSINESS WIRE)--Advanced technology company Booz Allen Hamilton (NYSE: BAH) today announced it was awarded an Other Transaction Authority agreement by the U.S. Space Force Space Systems Command as part of Golden Dome for America's Space-Based Interceptor (SBI) program. The award focuses on the development and delivery of a prototype system for space-based missile defense. “Booz Allen is uniquely positioned to field emerging capabilities that drive the critical mission of Golden Do...
IonQ Launches Commercial InSAR Capability, Enabling Automated, Millimeter-Scale Earth Monitoring
COLLEGE PARK, Md.--(BUSINESS WIRE)--IonQ (NYSE: IONQ), the world's leading quantum technology company, today announced the commercial launch of Interferometric Synthetic Aperture Radar (InSAR) capabilities through its space missions line. The offering enables millimeter-precision ground deformation monitoring with fully automated tasking and data delivery – enabling customers to detect and track physical change on the Earth's surface consistently, at a frequency and scale never previously avail...
Gallagher Launches Gallagher Blueprint, Pairing AI and Expert Insight to Produce Risk Profile Scores and Market-Ready Action Plans
ROLLING MEADOWS, Ill., May 4, 2026 /PRNewswire/ -- Gallagher, one of the world's largest insurance brokerage and risk management firms, today launched Gallagher Blueprint, a strategic framework that combines AI-driven analytics, Gallagher's proprietary data, and deep niche expertise, to help clients strengthen their risk profile and structure stronger, cost-efficient insurance programs...
DXP Enterprises, Inc. Announces First Quarter 2026 Earnings Release and Conference Call
HOUSTON--(BUSINESS WIRE)-- #DXPE--DXP Enterprises, Inc. (the “Company”) (NASDAQ: DXPE), a leading business to business products and service distributor that adds value and total cost savings solutions to MRO and OEM customers in virtually every industry, plans to issue a press release announcing its financial results for the first quarter ended March 31, 2026, on Thursday, May 7th. The earnings announcement will be released before the market opens. DXP will host a conference call, to be webcast live, o...